IGF-1R is a multifunctional membrane-associated tyrosine kinase (DeCordova et al., 2020), which potentially facilitates the glioma patient’s response to kinase-inhibiting drugs such as WZ.1.184, BMS.509744, and A770041. Here, IGF1R is linked to central nervous system cancer.